Present system contains only the N-terminal 2/3
of the Tissue Inhibitor of Metalloproteinase,
whereas the related system is full-length.
In addition, the present system has been studied
in solution as a complex with a mutant matrix
metalloproteinase-3(E202Q).
The system of PDB 1D2B has been studied
in solution as a complex with a mutant matrix
metalloproteinase-3(E202Q).

N-terminus of Tissue Inhibitor of Metalloproteinases-1/Matrix MetalloProteinase-3(E202Q)(deltaC) complex

N-TIMP-1 inhibits the enzymatic activity of matrix metalloproteinases-1,-2, &-3 with Ki values less than 2.0 nM.

Present system contains only the N-terminal 2/3 of the Tissue Inhibitor of Metalloproteinase, whereas the related system is full-length. In addition, the present system has been studied in solution as a complex with a mutant matrix metalloproteinase-3(E202Q).

The present system has been studied
in solution as a complex with a mutant matrix
metalloproteinase-3(E202Q).

Information obtained from PDB's Chemical Component Dictionary at http://wwpdb-remediation.rutgers.edu/downloads.html Downloaded on Mon Jun 13 13:55:41 2011

Information obtained from PDB's Chemical Component Dictionary at http://wwpdb-remediation.rutgers.edu/downloads.html Downloaded on Mon Jun 13 14:00:03 2011

Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3.

Global orientation of bound MMP-3 and N-TIMP-1 in solution via residual dipolar couplings.

tissue inhibitor of matrix metalloproteinases

N-terminus of Tissue Inhibitor of Metalloproteinases-1/Matrix MetalloProteinases-3(catalytic domain) complex

Metalloproteinases-1/Matrix MetalloProteinase-3(catalytic domain, residue 83-255)

X-Ray Structure Of Human Stromelysin Catalytic Domain Complexed With Non-Peptide Inhibitors: Implications For Inhibitor Selecti

Design And Synthesis Of Conformationally-Constrained Mmp Inhibitors

Solution Structure Of The Catalytic Domain Of Human Stromelysin-1 Complexed To A Potent Non-Peptidic Inhibitor, Nmr, 20 Structu

Discovery Of Potent, Achiral Matrix Metalloproteinase Inhibitors

Human Stromelysin-1 Catalytic Domain Complexed With Ro-26-2812

Human Stromelysin-1 (E202q) Catalytic Domain Complexed With Ro-26-2812

X-Ray Structure Of Human Stromelysin Catalytic Domain Complexes With Non-Peptide Inhibitors: Implication For Inhibitor Selectiv

Crystal Structure Of The Stromelysin Catalytic Domain At 2.0 A Resolution

Crystal Structure Of Mmp3 Complexed With A Thiazepine Based Inhibitor.

Crystal Structure Of Mmp3 Complexed With A Modified Proline Scaffold Based Inhibitor.

Crystal Structure Of Mmp3 Complexed With A Piperazine Based Inhibitor.

Crystal Structure Of Mmp3 Complexed With A Heterocycle- Based Inhibitor

Heterocycle-Based Mmp Inhibitor With P2'substituents

A Carboxylic Acid Based Inhibitor In Complex With Mmp3

X-ray Structure Of A Novel Matrix Metalloproteinase Inhibitor Complexed To Stromelysin

Crystal Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With The N-Carboxy-Alkyl Inhibitor L-764,

Orientation In Solution Of Mmp-3 Catalytic Domain And N- Timp-1 From Residual Dipolar Couplings

Crystal Structure Of Stromelysin Catalytic Domain

Crystal Structure Of Fibroblast Stromelysin-1: The C-Truncated Human Proenzyme

Crystal Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With The N-Carboxy-Alkyl Inhibitor L-702,

Stromelysin-1 Catalytic Domain With Hydrophobic Inhibitor Bound, Ph 7.0, 32oc, 20 Mm Cacl2, 15% Acetonitrile; Nmr Ensemble Of 2

Stromelysin-1 Catalytic Domain With Hydrophobic Inhibitor Bound, Ph 7.0, 32oc, 20 Mm Cacl2, 15% Acetonitrile; Nmr Average Of 20

Crystal Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With Thiadiazole Inhibitor Pnu-142372

Stromelysin-1 (Mmp-3) Complexed To A Hydroxamic Acid Inhibitor

Solution Structure Of Matrix Metalloproteinase 3 (Mmp-3) In The Presence Of N-Isobutyl-N-[4- Methoxyphenylsulfonyl]glycyl Hydro

Solution Structure Of Matrix Metalloproteinase 3 (mmp-3) In The Presence Of N-hydroxy-2-[n-(2-hydroxyethyl)biphenyl-4- Sulfonam

Solution Structure Of Matrix Metalloproteinase 3 (Mmp-3) In The Presence Of 3-4'-Cyanobyphenyl-4-Yloxy)-N- Hdydroxypropionamide

Catalytic Domain Of Human Stromelysin-1 At Ph 5.5 And 40oc Complexed With Inhibitor

Crystal Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With Thiadiazole Inhibitor Pnu-141803

Catalytic Domain Of Stromelysin-1 In Complex With N-Hydroxy-2-(4- Methoxy-N-(Pyridine-3-Ylmethyl)phenylsulfonamido)acetamide

Catalytic Domain Of Stromelysin-1 In Complex With N-Hydroxy-2-(4- Methylphenylsulfonamido)acetamide

Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With The Thiadiazole Inhibitor Ipnu-107859, Nmr,

Structure Of Mmp3 Complexed With A Platinum-based Inhibitor.

Structure Of Mmp3 Complexed With Nngh Inhibitor

matrix metalloproteinase 3 preproprotein variant [Homo sapiens]

prostromelysin=matrix metalloproteinase [human, Peptide, 477 aa]

matrix metalloproteinase-3 [Homo sapiens]

stromelysin catalytic domain [synthetic construct]

Matrix metallopeptidase 3 (stromelysin 1, progelatinase) [Homo sapiens]

stromelysin-1 preproprotein [Homo sapiens]

PREDICTED: stromelysin-1 [Nomascus leucogenys]

PREDICTED: stromelysin-1 [Gorilla gorilla gorilla]

RecName: Full=Stromelysin-1; Short=SL-1; AltName: Full=Matrix metalloproteinase-3; Short=MMP-3; AltName: Full=Transin-1; Flags:

Stromelysin-1 precursor (SL-1) (Matrix metalloproteinase-3) (MMP-3) (Transin-1)

PREDICTED: matrix metalloproteinase 3 isoform 4 [Pan troglodytes]

PREDICTED: matrix metalloproteinase 3 isoform 2 [Pan troglodytes]

PREDICTED: matrix metalloproteinase 3 isoform 1 [Pan troglodytes]

matrix metalloproteinase 3 preproprotein [Homo sapiens]

Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1

Solution Structure Of Matrix Metalloproteinase 3 (Mmp-3) In The Presence Of 3-4'-Cyanobyphenyl-4-Yloxy)-N- Hdydroxypropionamide (Mmp-3 Inhibitor Vii)

Solution Structure Of Matrix Metalloproteinase 3 (Mmp-3) In The Presence Of N-Hydroxy-2-[n-(2-Hydroxyethyl)biphenyl-4- Sulfonamide] Hydroxamic Acid (Mlc88)

Solution Structure Of Matrix Metalloproteinase 3 (Mmp-3) In The Presence Of N-Isobutyl-N-[4- Methoxyphenylsulfonyl]glycyl Hydroxamic Acid (Nngh)

Stromelysin-1 Catalytic Domain With Hydrophobic Inhibitor Bound, Ph 7.0, 32oc, 20 Mm Cacl2, 15% Acetonitrile; Nmr Average Of 20 Structures Minimized With Restraints

Stromelysin-1 Catalytic Domain With Hydrophobic Inhibitor Bound, Ph 7.0, 32oc, 20 Mm Cacl2, 15% Acetonitrile; Nmr Ensemble Of 20 Structures

Crystal Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With The N-Carboxy- Alkyl Inhibitor L-702,842

Crystal Structure Of Fibroblast Stromelysin-1: The C- Truncated Human Proenzyme

Crystal Structure Of The Catalytic Domain Of Human Fibroblast Stromelysin-1 Inhibited With The N-Carboxy- Alkyl Inhibitor L-764,004

X-Ray Structure Of Human Stromelysin Catalytic Domain Complexes With Non-Peptide Inhibitors: Implication For Inhibitor Selectivity

Human Stromelysin-1 Catalytic Domain Complexed With Ro-26- 2812

Solution Structure Of The Catalytic Domain Of Human Stromelysin-1 Complexed To A Potent Non-Peptidic Inhibitor, Nmr, 20 Structures

X-Ray Structure Of Human Stromelysin Catalytic Domain Complexed With Non-Peptide Inhibitors: Implications For Inhibitor Selectivity

Matrix MetalloProteinases-3 or stromelysin 1

MatrixMetalloProteinases-3(catalytic domain)

Backbone and side chain 1H, 13C, and 15N Chemical Shift Assignments for N-TIMP-1 in N-TIMP-1/MMP-3(E202Q) Complex

At times, use of NMRPIPE software for
an intermediate data conversion was
necessary before processing with Sybyl.